㽶Ƶ

Skip to main content

Aimee Hersh wins the “Outstanding Service Award” for CARRA 2024 Community Awards

The Childhood Arthritis and Rheumatology Research Alliance (CARRA) named Aimee Hersh, MD, the recipient of the “Outstanding Service Award” for the 2024 Community Awards.

The awards, which were presented at CARRA’s Annual Scientific Meeting, honor people who have made outstanding efforts and achievements to advance pediatric rheumatology research and ultimately improve the lives of kids living with pediatric rheumatic and related autoimmune diseases. These winners have shown the utmost dedication to CARRA’s mission to conduct collaborative research to prevent, treat, and cure pediatric rheumatic diseases.

“The Community Awards recognize responsive, respectful and collaborative individuals who have made significant contributions to CARRA and/or to pediatric rheumatology research,” said CARRA President Robert Colbert, MD, PhD. “We are delighted to celebrate their achievements and thank them for their incredible efforts and dedication to our community.”

Hersh is an Associate Professor in Pediatric Rheumatology and Division Chief of Pediatric Rheumatology at the Spencer Fox Eccles School of Medicine and Intermountain Healthcare Primary Children’s Hospital. 

Aimee Hersh, MD

She serves as an elected member of the CARRA Steering Committee and Chair of the Lupus Committee. Her research focuses on understanding the long-term medical and psychosocial outcomes of patients with childhood-onset systemic lupus erythematosus and juvenile idiopathic arthritis.

###

The Childhood Arthritis and Rheumatology Research Alliance (CARRA) is a 501(c)3 registered non-profit organization. CARRA’s mission is to conduct collaborative research to prevent, treat, and cure pediatric rheumatic diseases. Formed in 2002 by a small group of dedicated physicians, CARRA has grown to have more than 700 members at more than 120 institutions in North America and abroad. CARRA has built the largest observational multi-center Registry for pediatric rheumatic disease and operates two biobanks – one in the U.S. and one in Canada. .